<!DOCTYPE html>
<html>
<head>
  <!-- Standard Meta -->
  <meta charset="utf-8">

  <!-- Site Properties -->
  <title>STRchive</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/semantic-ui/2.2.7/semantic.min.css">


  <style type="text/css">

    .hidden.menu {
      display: none;
    }

    .masthead.segment {
      min-height: 700px;
      padding: 1em 0em;
    }
    .masthead .logo.item img {
      margin-right: 1em;
    }
    .masthead .ui.menu .ui.button {
      margin-left: 0.5em;
    }
    .masthead h1.ui.header {
      margin-top: 3em;
      margin-bottom: 0em;
      font-size: 4em;
      font-weight: normal;
    }
    .masthead h2 {
      font-size: 1.7em;
      font-weight: normal;
    }

    .ui.vertical.stripe {
      padding: 8em 0em;
    }
    .ui.vertical.stripe h3 {
      font-size: 2em;
    }
    .ui.vertical.stripe .button + h3,
    .ui.vertical.stripe p + h3 {
      margin-top: 3em;
    }
    .ui.vertical.stripe .floated.image {
      clear: both;
    }
    .ui.vertical.stripe p {
      font-size: 1.33em;
    }
    .ui.vertical.stripe .horizontal.divider {
      margin: 3em 0em;
    }

    .quote.stripe.segment {
      padding: 0em;
    }
    .quote.stripe.segment .grid .column {
      padding-top: 5em;
      padding-bottom: 5em;
    }

    .footer.segment {
      padding: 5em 0em;
    }

    .secondary.pointing.menu .toc.item {
      display: none;
    }

    @media only screen and (max-width: 700px) {
      .ui.fixed.menu {
        display: none !important;
      }
      .secondary.pointing.menu .item,
      .secondary.pointing.menu .menu {
        display: none;
      }
      .secondary.pointing.menu .toc.item {
        display: block;
      }
      .masthead.segment {
        min-height: 350px;
      }
      .masthead h1.ui.header {
        font-size: 2em;
        margin-top: 1.5em;
      }
      .masthead h2 {
        margin-top: 0.5em;
        font-size: 1.5em;
      }
    }


  </style>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.1.1/jquery.min.js"></script>
  <script>
  $(document)
    .ready(function() {

      // fix menu when passed
      $('.masthead')
        .visibility({
          once: false,
          onBottomPassed: function() {
            $('.fixed.menu').transition('fade in');
          },
          onBottomPassedReverse: function() {
            $('.fixed.menu').transition('fade out');
          }
        })
      ;

      // create sidebar and attach to menu open
      $('.ui.sidebar')
        .sidebar('attach events', '.toc.item')
      ;

    })
  ;
  </script>
</head>
<body>

<!-- Header -->
<div class="pusher">
  <div class="ui inverted vertical  center aligned segment">

    <div class="ui container">
      <div class="ui large secondary inverted pointing menu">
        <a class="toc item">
          <i class="sidebar icon"></i>
        </a>
        <a class="item" href="index.html">Home</a>
        <a class="item" href="about.html">About</a>
        <a class="active item" href="table.html">STR Database</a>
        <a class="item" href="plots.html">Plots</a>
        <a class="item" href="contribute.html">Contribute</a>
        <div class="right item">
          <a class="ui inverted button" href="index.html">STRchive</a>
          <a class="ui icon inverted button" href="https://github.com/hdashnow/STRchive">
            <i class="github icon"></i>
          </a>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="ui vertical stripe segment">


  <div class="ui middle aligned container">
  <h1 class="ui massive header">STRchive</h1>
  <p>STRchive (Short Tandem Repeat Archive) is a database of STRs associated with disease in humans.</p>
  <p>The full dataset can be viewed on 
    <a class="ui icon button label" href="https://github.com/hdashnow/STRchive">
      <i class="github icon"> GitHub</i>
    </a>
  </p>
  <br>
  
  
  <table id="table" class="ui sortable celled table" >
    <thead>
      <tr>
      
        <th>Position (hg38)</th>
      
        <th>Gene</th>
      
        <th>Disease</th>
      
        <th>Inheritance</th>
      
        <th>Motif</th>
      
      </tr>
      
    </thead>
    <tbody>
      
      <tr>
        
        <td>chrX:148500605-148500753</td>
        
        <td>AFF2/FMR2</td>
        
        <td>Fragile X syndrome, FRAXE type</td>
        
        <td>XR</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr2:100104799-100104824</td>
        
        <td>AFF3</td>
        
        <td>Intellectual disability associated with fragile site FRA2A</td>
        
        <td>AD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:67545317-67545419</td>
        
        <td>AR</td>
        
        <td>Spinal and bulbar muscular atrophy, Kennedy Disease</td>
        
        <td>XR</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:25013654-25013697</td>
        
        <td>ARX</td>
        
        <td>Early-infantile epileptic encephalopathy</td>
        
        <td>XR</td>
        
        <td>GCG</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:25013530-25013565</td>
        
        <td>ARX</td>
        
        <td>Partington syndrome</td>
        
        <td>XR</td>
        
        <td>GCG</td>
        
      </tr>
      
      <tr>
        
        <td>chr12:6936717-6936775</td>
        
        <td>ATN1</td>
        
        <td>Dentatorubral-Pallidoluysian Atrophy</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr6:16327634-16327724</td>
        
        <td>ATXN1</td>
        
        <td>Spinocerebellar Ataxia Type 1</td>
        
        <td>AD</td>
        
        <td>CTG</td>
        
      </tr>
      
      <tr>
        
        <td>chr22:45795355-45795424</td>
        
        <td>ATXN10</td>
        
        <td>Spinocerebellar Ataxia Type 10</td>
        
        <td>AD</td>
        
        <td>ATTCT</td>
        
      </tr>
      
      <tr>
        
        <td>chr12:111598950-111599019</td>
        
        <td>ATXN2</td>
        
        <td>Spinocerebellar Ataxia Type 2</td>
        
        <td>AD/AR</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr14:92071012-92071053</td>
        
        <td>ATXN3</td>
        
        <td>Spinocerebellar Ataxia Type 3/Machado-Joseph Disease</td>
        
        <td>AD</td>
        
        <td>CTG</td>
        
      </tr>
      
      <tr>
        
        <td>chr3:63912685-63912716</td>
        
        <td>ATXN7</td>
        
        <td>Spinocerebellar Ataxia Type 7</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr13:70139383-70139429</td>
        
        <td>ATXN8OS/ATXN8</td>
        
        <td>Spinocerebellar Ataxia Type 8</td>
        
        <td>AD</td>
        
        <td>CTG</td>
        
      </tr>
      
      <tr>
        
        <td>chr16:66490397-66490466</td>
        
        <td>BEAN1</td>
        
        <td>Spinocerebellar Ataxia Type 31</td>
        
        <td>AD</td>
        
        <td>TGGAA</td>
        
      </tr>
      
      <tr>
        
        <td>chr9:27573484-27573546</td>
        
        <td>C9orf72</td>
        
        <td>"In European populations, C9ORF72 repeat expansions were the most common (5.1 percent)" assessing genes in sporadic ALS</td>
        
        <td>AD</td>
        
        <td>GGGGCC</td>
        
      </tr>
      
      <tr>
        
        <td>chr19:13207859-13207898</td>
        
        <td>CACNA1A</td>
        
        <td>Spinocerebellar Ataxia Type 6</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr11:119206289-119206322</td>
        
        <td>CBL2</td>
        
        <td>Jacobsen syndrome (FRAX11B fragile site)</td>
        
        <td>AD</td>
        
        <td>CCG</td>
        
      </tr>
      
      <tr>
        
        <td>chr19:18786034-18786049</td>
        
        <td>COMP</td>
        
        <td>Multiple epiphyseal dysplasia, Pseudoachondroplasia</td>
        
        <td>AD</td>
        
        <td>GTC</td>
        
      </tr>
      
      <tr>
        
        <td>chr1:57367044-57367125</td>
        
        <td>DAB1</td>
        
        <td>Spinocerebellar Ataxia Type 37</td>
        
        <td>AD</td>
        
        <td>ATTTC</td>
        
      </tr>
      
      <tr>
        
        <td>chr12:50505002-50505022</td>
        
        <td>DIP2B</td>
        
        <td>Intellectual developmental disorder, FRA12A type</td>
        
        <td>AD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:31284557-31284605</td>
        
        <td>DMD</td>
        
        <td>Duchenne muscular dystrophy</td>
        
        <td>XR</td>
        
        <td>TTC</td>
        
      </tr>
      
      <tr>
        
        <td>chr19:45770204-45770266</td>
        
        <td>DMPK</td>
        
        <td>Myotonic Dystrophy Type 1</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:147912037-147912111</td>
        
        <td>FMR1</td>
        
        <td>fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated primary ovarian insufficiency FXPOI/POF1</td>
        
        <td>XD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr3:138946020-138946062</td>
        
        <td>FOXL2</td>
        
        <td>Blepharophimosis, epicanthus inversus, and ptosis</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr9:69037287-69037289</td>
        
        <td>FXN</td>
        
        <td>Friedreich ataxia</td>
        
        <td>AR</td>
        
        <td>AAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr19:14496041-14496074</td>
        
        <td>GIPC1</td>
        
        <td>Oculopharyngodistal myopathy</td>
        
        <td>AD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr2:190880873-190880920</td>
        
        <td>GLS</td>
        
        <td>Glutaminase deficiency</td>
        
        <td>AR</td>
        
        <td>GCA</td>
        
      </tr>
      
      <tr>
        
        <td>chr7:27199678-27199732</td>
        
        <td>HOXA13</td>
        
        <td>Hand-foot-uterus syndrome</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr7:27199825-27199861</td>
        
        <td>HOXA13</td>
        
        <td>Hand-foot-uterus syndrome</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr7:27199924-27199966</td>
        
        <td>HOXA13</td>
        
        <td>Hand-foot-uterus syndrome</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr2:176093058-176093103</td>
        
        <td>HOXD13</td>
        
        <td>Syndactyly</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr4:3074877-3074940</td>
        
        <td>HTT</td>
        
        <td>Huntington disease</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr16:87604283-87604329</td>
        
        <td>JPH3</td>
        
        <td>Huntington disease-like 2</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr8:104,588,972-104,588,999</td>
        
        <td>LRP12</td>
        
        <td>Oculopharyngodistal myopathy type 1</td>
        
        <td>AD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr5:10356339-10356411</td>
        
        <td>MARCH6</td>
        
        <td>Familial adult myoclonic epilepsy type 3</td>
        
        <td>AD</td>
        
        <td>TTTCA</td>
        
      </tr>
      
      <tr>
        
        <td>chr15:22786677-22786701</td>
        
        <td>NIPA1</td>
        
        <td>Amyotrophic lateral sclerosis</td>
        
        <td>AD</td>
        
        <td>GCG</td>
        
      </tr>
      
      <tr>
        
        <td>chr20:2652733-2652775</td>
        
        <td>NOP56</td>
        
        <td>Spinocerebellar ataxia type 36</td>
        
        <td>AD</td>
        
        <td>GGCCTG</td>
        
      </tr>
      
      <tr>
        
        <td>chr1:149390803-149390842</td>
        
        <td>NOTCH2NLC</td>
        
        <td>neuronal intranuclear inclusion disease, Alzheimer disease and parkinsonism phenotype</td>
        
        <td>AD</td>
        
        <td>GGC</td>
        
      </tr>
      
      <tr>
        
        <td>chr10:79826383-79826404</td>
        
        <td>NUTM2B-AS1</td>
        
        <td>Oculopharyngeal myopathy with leukoencephalopathy 1</td>
        
        <td>AD</td>
        
        <td>GGC</td>
        
      </tr>
      
      <tr>
        
        <td>chr14:23321472-23321492</td>
        
        <td>PABPN1</td>
        
        <td>Oculopharyngeal muscular dystrophy</td>
        
        <td>AD/AR</td>
        
        <td>GCG</td>
        
      </tr>
      
      <tr>
        
        <td>chr4:41745976-41746022</td>
        
        <td>PHOX2B</td>
        
        <td>Congenital central hypoventilation syndrome</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr15:89333589-89333629</td>
        
        <td>POLG</td>
        
        <td>progressive external ophthalmoplegia, Parkinson’s disease</td>
        
        <td>-</td>
        
        <td>CTG</td>
        
      </tr>
      
      <tr>
        
        <td>chr5:146878728-146878759</td>
        
        <td>PPP2R2B</td>
        
        <td>Spinocerebellar ataxia type 12</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr9:130681606-130681639</td>
        
        <td>PRDM12</td>
        
        <td>Hereditary sensory and autonomic neuropathy type VIII</td>
        
        <td>AR</td>
        
        <td>GCC</td>
        
      </tr>
      
      <tr>
        
        <td>chr4:159342527-159342618</td>
        
        <td>RAPGEF2</td>
        
        <td>Familial adult myoclonic epilepsy type 7</td>
        
        <td>AD</td>
        
        <td>TTTCA</td>
        
      </tr>
      
      <tr>
        
        <td>chr4:39348425-39348483</td>
        
        <td>RFC1</td>
        
        <td>Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome</td>
        
        <td>AR</td>
        
        <td>AAGGG/ACAGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr12:123533720-123533755</td>
        
        <td>RILPL1</td>
        
        <td>oculopharyngodistal myopathy type 4</td>
        
        <td>AD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr6:45422750-45422792</td>
        
        <td>RUNX2</td>
        
        <td>Cleidocranial dysplasia</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr8:118366813-118366918</td>
        
        <td>SAMD12</td>
        
        <td>Familial adult myoclonic epilepsy type 1</td>
        
        <td>AD</td>
        
        <td>TTTCA/TTTGA</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:140504316-140504361</td>
        
        <td>SOX3</td>
        
        <td>X-linked panhypopituitarism ;  X-linked mental retardation with isolated growth hormone               </td>
        
        <td>XR</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr2:96197067-96197121</td>
        
        <td>STARD7</td>
        
        <td>Familial adult myoclonic epilepsy 2</td>
        
        <td>AD</td>
        
        <td>GAAAT</td>
        
      </tr>
      
      <tr>
        
        <td>chr6:170561907-170562017</td>
        
        <td>TBP</td>
        
        <td>Spinocerebellar ataxia type 17</td>
        
        <td>AD</td>
        
        <td>CAG/CAA</td>
        
      </tr>
      
      <tr>
        
        <td>chr22:19766762-19766807</td>
        
        <td>TBX1</td>
        
        <td>Tetralogy of Fallot</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr18:55586155-55586227</td>
        
        <td>TCF4</td>
        
        <td>Fuchs endothelial corneal dystrophy 3</td>
        
        <td>AD</td>
        
        <td>CAG</td>
        
      </tr>
      
      <tr>
        
        <td>chr16:24613439-24613532</td>
        
        <td>TNRC6A</td>
        
        <td>Familial adult myoclonic epilepsy type 6</td>
        
        <td>AD</td>
        
        <td>TTTCA</td>
        
      </tr>
      
      <tr>
        
        <td>chr16:17470921-17470922</td>
        
        <td>XYLT1</td>
        
        <td>Baratela-Scott Syndrome/Desbuquois dysplasia 2</td>
        
        <td>AR</td>
        
        <td>CCG</td>
        
      </tr>
      
      <tr>
        
        <td>chr3:183712188-183712222</td>
        
        <td>YEATS2</td>
        
        <td>Familial adult myoclonic epilepsy 4</td>
        
        <td>AD</td>
        
        <td>TTTCA</td>
        
      </tr>
      
      <tr>
        
        <td>chr13:99985448-99985493</td>
        
        <td>ZIC2</td>
        
        <td>Holoprosencephaly-5</td>
        
        <td>AD</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chrX:137566826-137566856</td>
        
        <td>ZIC3</td>
        
        <td>X-linked VACTERL syndrome</td>
        
        <td>XR</td>
        
        <td>GCN</td>
        
      </tr>
      
      <tr>
        
        <td>chr7:55887601-55887639</td>
        
        <td>ZNF713</td>
        
        <td>Autism spectrum disorder associated with fragile site FRA7A</td>
        
        <td>AD</td>
        
        <td>CGG</td>
        
      </tr>
      
      <tr>
        
        <td>chr3:129172577-129172659</td>
        
        <td>ZNF9 / CNBP1</td>
        
        <td>Myotonic Dystrophy Type 2</td>
        
        <td>AD</td>
        
        <td>CCTG</td>
        
      </tr>
      
    </tbody>
  </table>
  
  </div>
    

</div>

<!-- Footer -->
<div class="ui inverted vertical footer segment">
  <div class="ui container">
    <div class="ui stackable inverted divided equal height stackable grid">
      <div class="three wide column">
        <h4 class="ui inverted header" href="about.html">About</h4>
        <div class="ui inverted link list">
          <a class="item" href="https://github.com/hdashnow/STRchive/issues">Contact Us</a>
        </div>
      </div>
      <div class="three wide column">
        <h4 class="ui inverted header" href="contribute.html">Contribute</h4>
        <div class="ui inverted link list">
          <a class="item" href="contribute.html">How To Contribute</a>
        </div>
      </div>
      <div class="ten wide column">
        <h4 class="ui inverted header">Research use only</h4>
        <p>The content on and linked from this website 
          does not constitute and shall not be construed as constituting medical or legal advice of any kind whatsoever, 
          nor is it a substitute for professional medical advice, diagnosis and treatment.
        </p>
      </div>
    </div>
  </div>
</div>
</div>

</body>

</html>